Opening book details…
About this Medicine article
Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial by Matthay, K. K.; Weiss, B.; Villablanca, J. G.; Maris, J. M.; Yanik, G. A.; DuBois, S. G.; Stubbs, J.; Groshen, S.; Tsao-Wei, D.; Hawkins, R.; Jackson, H.; Goodarzian, F.; Daldrup-Link, H.; Panigrahy, A.; Towbin, A.; Shimada, H.; Barrett, J.; LaFrance, N.; Babich, J. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Matthay, K. K.; Weiss, B.; Villablanca, J. G.; Maris, J. M.; Yanik, G. A.; DuBois, S. G.; Stubbs, J.; Groshen, S.; Tsao-Wei, D.; Hawkins, R.; Jackson, H.; Goodarzian, F.; Daldrup-Link, H.; Panigrahy, A.; Towbin, A.; Shimada, H.; Barrett, J.; LaFrance, N.; Babich, J.
- Publisher
- The Society of Nuclear Medicine; Society of Nuclear Medicine; Society of Nuclear Medicine, Inc. (ISSN 0161-5505)
- Published
- 2012
- Field
- Medicine (Health Sciences)